Clinical Trials Logo

Vaginitis clinical trials

View clinical trials related to Vaginitis.

Filter by:

NCT ID: NCT02014428 Completed - Atrophic Vaginitis Clinical Trials

Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis

Start date: n/a
Phase: Phase 4
Study type: Interventional

To evaluate the effectiveness of low molecular weight hyaluronic acid oral tablets for the treatment of atrophic vaginitis.

NCT ID: NCT01993524 Completed - Bacterial Vaginosis Clinical Trials

Supplementation of Standard Antibiotic Therapy With Oral Probiotics for Bacterial Vaginosis

Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of this study was to determine whether supplementation of standard antibiotic therapy with oral probiotic preparation prOVag containing lactic acid bacteria influences recurrence of bacterial vaginosis/vaginitis.

NCT ID: NCT01874158 Completed - Clinical trials for Trichomonas Vaginitis

DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women

Start date: November 2012
Phase: Phase 4
Study type: Observational

The objective of this study is to screen treated Trichomonas vaginalis (TV) positive women weekly using culture and Polymerase Chain Reaction (PCR) to determine how long TV DNA is detectable post treatment and to examine potential confounders to clearance such as bacterial vaginosis.

NCT ID: NCT01867164 Completed - Vaginitis Clinical Trials

A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of this comparative study is to evaluate the efficacy of an ovule with triple active agents (terconazole, clindamycin and fluocinolone) versus another ovule with triple active agents (nystatin, metronidazole and fluocinolone) in the treatment of symptoms caused by the presence of vaginitis (inflammation of the vagina) or bacterial vaginosis (polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli).

NCT ID: NCT01832480 Completed - Clinical trials for Vaginitis Trichomonal or Due to Trichomonas

Trichomonas Vaginalis Repeat Infections Among HIV Negative Women

Start date: October 6, 2014
Phase: Phase 3
Study type: Interventional

The overall goal of this project is to determine the influence of patient treatment and host factors on repeat Trichomonas vaginalis (TV) infections among HIV-negative women

NCT ID: NCT01593124 Completed - Vaginal Infections Clinical Trials

Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation

Biomarkers
Start date: May 2012
Phase: Phase 2
Study type: Interventional

This study investigates the response of vaginal and cervical tissue after exposure to three vaginal products: hydroxyethyl cellulose (HEC) placebo, nonoxynol-9 (N9) and imiquimod (IMQ) cream.

NCT ID: NCT01507454 Completed - Menopause Clinical Trials

Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

Start date: April 2006
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of this study is to investigate the self-reported impact of Vagifem® (estradiol) treatment on urogenital discomfort in women with atrophic vaginitis due to oestrogen deficiency.

NCT ID: NCT01486979 Completed - Menopause Clinical Trials

Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

Start date: January 2007
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to to evaluate the extent of systemic absorption of estradiol during treatment with two different doses of estradiol in postmenopausal women with atrophic vaginitis.

NCT ID: NCT01436513 Completed - Menopause Clinical Trials

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

Start date: October 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the bioequivalence and food effect for a new Premarin formulation compared with a Premarin reference tablet in Japanese healthy postmenopausal women.

NCT ID: NCT01420510 Recruiting - Vaginitis Clinical Trials

Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis

Start date: September 2011
Phase: Phase 2/Phase 3
Study type: Interventional

We hypothesise that the use of Adelmidrol (Saginil in vaginal cannulas) can reduce the incidence and magnitude of vaginitis in patients affected by gynecologic malignancies.